However, current consensus ROP screening guidelines published by the American Academy of Pediatrics in conjunction with the American Academy of Ophthalmology recommend the use of intravitreal anti-VEGF as a promising treatment for ROP type 1 and other types of ROP (10). This evidence concerns the gene VEGFA and retinopathy of prematurity.